WPI 3367
Pill imprint WPI 3367 has been identified as Zolpidem tartrate 10 mg.
Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy.
Zolpidem 10 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Zolpidem tartrate Images
- Imprint:
-
WPI
3367 - Strength:
- 10 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
crospovidone
hypromellose
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
titanium dioxide
- Drug Class:
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-3367
Advertisement
More Zolpidem Tartrate resources
- Zolpidem
- Zolpidem (Wolters Kluwer)
- Zolpidem Extended-Release Tablets (Wolters Kluwer)
- Zolpidem Oral Spray (Wolters Kluwer)
- zolpidem (Cerner Multum)
- zolpidem Oral, Oromucosal (Micromedex) - Includes Dosage Information
- Zolpidem Tartrate (AHFS DI)
- Zolpidem (FDA)
- Zolpidem Extended Release (FDA)
- Zolpidem Tartrate (Wolters Kluwer)
Search Again
